Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Processing of Ultrasound Results
3.2. Processing of PCR Results
3.3. Neonatological Follow-Up
4. Discussion
4.1. Abnormalities Detected on Ultrasound Examination
4.2. PCR Tests from Amniotic Fluid
4.3. Follow-Up Examination of the Newborn
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Flegr, J.; Prandota, J.; Sovičková, M.; Israili, Z.H. Toxoplasmosis—A global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE 2014, 9, e90203. [Google Scholar] [CrossRef] [PubMed]
- Furtado, J.M.; Smith, J.R.; Belfort, R., Jr.; Gattey, D.; Winthrop, K.L. Toxoplasmosis: A global threat. J. Glob. Infect. Dis. 2011, 3, 281–284. [Google Scholar] [CrossRef] [PubMed]
- CDC. About Toxoplasmosis. National Center for Health Statistics. 2024. Available online: https://www.cdc.gov/toxoplasmosis/about/index.html (accessed on 15 May 2024).
- Fallahi, S.; Rostami, A.; Nourollahpour Shiadeh, M.; Behniafar, H.; Paktinat, S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J. Gynecol. Obstet. Hum. Reprod. 2018, 47, 133–140. [Google Scholar] [CrossRef] [PubMed]
- Torgerson, P.R.; Mastroiacovo, P. The global burden of congenital toxoplasmosis: A systematic review. Bull. World Health Organ. 2013, 91, 501–508. [Google Scholar] [CrossRef]
- ECDC. European Centre for Disease Prevention and Control. Congenital toxoplasmosis. In Annual Epidemiological Report for 2018; 2021 Stockholm. Available online: https://www.ecdc.europa.eu/en/publications-data/congenital-toxoplasmosis-annual-epidemiological-report-2018 (accessed on 9 November 2021).
- Voekt, C.A.; Rinderknecht, T.; Hirsch, H.H.; Blaich, A.; Hösli, I.M. Ultrasound indications for maternal STORCH testing in pregnancy. Swiss Med. Wkly. 2017, 147, w14534. [Google Scholar] [CrossRef]
- Belanger, B.G.; Lui, F. Embryology, Teratology TORCH. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2024. [Google Scholar]
- Gilbert, G.L. 1: Infections in pregnant women. Med. J. Aust. 2002, 176, 229–236. [Google Scholar] [CrossRef]
- Kochanowsky, J.A.; Koshy, A.A. Toxoplasma gondii. Curr. Biol. 2018, 28, R770–R771. [Google Scholar] [CrossRef]
- Jones, C.J.; Harris, L.K.; Whittingham, J.; Aplin, J.D.; Mayhew, T.M. A re-appraisal of the morphophenotype and basal lamina coverage of cytotrophoblasts in human term placenta. Placenta 2008, 29, 215–219. [Google Scholar] [CrossRef]
- Arora, N.; Sadovsky, Y.; Dermody, T.S.; Coyne, C.B. Microbial Vertical Transmission during Human Pregnancy. Cell Host Microbe 2017, 21, 561–567. [Google Scholar] [CrossRef] [PubMed]
- Shiono, Y.; Mun, H.S.; He, N.; Nakazaki, Y.; Fang, H.; Furuya, M.; Aosai, F.; Yano, A. Maternal-fetal transmission of Toxoplasma gondii in interferon-gamma deficient pregnant mice. Parasitol. Int. 2007, 56, 141–148. [Google Scholar] [CrossRef]
- Márquez-Mauricio, A.; Caballero-Ortega, H.; Gómez-Chávez, F. Congenital Toxoplasmosis Diagnosis: Current Approaches and New Insights. Acta Parasitol. 2023, 68, 473–480. [Google Scholar] [CrossRef] [PubMed]
- Burg, J.L.; Grover, C.M.; Pouletty, P.; Boothroyd, J.C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 1989, 27, 1787–1792. [Google Scholar] [CrossRef] [PubMed]
- Galvani, A.T.; Christ, A.P.G.; Padula, J.A.; Barbosa, M.R.F.; de Araújo, R.S.; Sato, M.I.Z.; Razzolini, M.T.P. Real-time PCR detection of Toxoplasma gondii in surface water samples in São Paulo, Brazil. Parasitol. Res. 2019, 118, 631–640. [Google Scholar] [CrossRef]
- Bollani, L.; Auriti, C.; Achille, C.; Garofoli, F.; De Rose, D.U.; Meroni, V.; Salvatori, G.; Tzialla, C. Congenital Toxoplasmosis: The State of the Art. Front. Pediatr. 2022, 10, 894573. [Google Scholar] [CrossRef]
- Weiss, L.M.; Dubey, J.P. Toxoplasmosis: A history of clinical observations. Int. J. Parasitol. 2009, 39, 895–901. [Google Scholar] [CrossRef] [PubMed]
- Kota, A.S.; Shabbir, N. Congenital Toxoplasmosis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
- McAuley, J.B. Congenital Toxoplasmosis. J. Pediatric Infect. Dis. Soc. 2014, 3 (Suppl. 1), S30–S35. [Google Scholar] [CrossRef] [PubMed]
- Wallon, M.; Kodjikian, L.; Binquet, C.; Garweg, J.; Fleury, J.; Quantin, C.; Peyron, F. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004, 113, 1567–1572. [Google Scholar] [CrossRef]
- Mendez, O.A.; Koshy, A.A. Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. PLoS Pathog. 2017, 13, e1006351. [Google Scholar] [CrossRef]
- Saso, A.; Bamford, A.; Grewal, K.; Noori, M.; Hatcher, J.; D’Arco, F.; Guy, E.; Lyall, H. Fifteen-minute consultation: Management of the infant born to a mother with toxoplasmosis in pregnancy. Arch. Dis. Child. Educ. Pract. Ed. 2020, 105, 262–269. [Google Scholar] [CrossRef] [PubMed]
- Guerina, N.G.; Hsu, H.W.; Meissner, H.C.; Maguire, J.H.; Lynfield, R.; Stechenberg, B.; Abroms, I.; Pasternack, M.S.; Hoff, R.; Eaton, R.B.; et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 1994, 330, 1858–1863. [Google Scholar] [CrossRef]
- Deganich, M.; Boudreaux, C.; Benmerzouga, I. Toxoplasmosis Infection during Pregnancy. Trop. Med. Infect. Dis. 2022, 8, 3. [Google Scholar] [CrossRef] [PubMed]
- Codaccioni, C.; Picone, O.; Lambert, V.; Maurice, P.; Pomar, L.; Winer, N.; Guibaud, L.; Lavergne, R.A.; Saliou, A.H.; Quinio, D.; et al. Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses. Prenat. Diagn. 2020, 40, 1741–1752. [Google Scholar] [CrossRef] [PubMed]
- Hohlfeld, P.; MacAleese, J.; Capella-Pavlovski, M.; Giovangrandi, Y.; Thulliez, P.; Forestier, F.; Daffos, F. Fetal toxoplasmosis: Ultrasonographic signs. Ultrasound Obstet. Gynecol. 1991, 1, 241–244. [Google Scholar] [CrossRef] [PubMed]
- de Oliveira Azevedo, C.T.; do Brasil, P.E.; Guida, L.; Lopes Moreira, M.E. Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. PLoS ONE 2016, 11, e0149938. [Google Scholar] [CrossRef] [PubMed]
- Caceres, A.; Caceres-Alan, A.; Caceres-Alan, T. Toxoplasma gondii infections in pediatric neurosurgery. Childs Nerv. Syst. 2024, 40, 295–301. [Google Scholar] [CrossRef] [PubMed]
- Reynolds, M.M.M.; Chisholm, S.A.M.; Schroeder, R.; Lueder, G.T. Visual Outcomes in Presumed Congenital Foveal Toxoplasmosis. Am. J. Ophthalmol. 2020, 214, 9–13. [Google Scholar] [CrossRef]
- Ferreira, L.; Sanfins, M.D.; Pinto, J.D.; Skarzynski, P.H.; Skarżyńska, M.B.; Vieira Biaggio, E.P. Congenital toxoplasmosis and auditory disorders: A literature review. Front. Psychol. 2023, 14, 1286211. [Google Scholar] [CrossRef]
Amniotic Fluid PCR Positive n = 8 | Amniotic Fluid PCR Negative n = 230 | |
---|---|---|
Delivery | 3 (38%) | 216 (93.9%) |
Abortion | 5 (62%) | 2 (0.8%) |
Stillbirth | 1 (0.5%) |
Prenatal Factors | Complications (n = 22) | No Complications (n = 117) | Total | p |
---|---|---|---|---|
Age over 37 years | 1 | 13 | 14 | 0.407890 |
PCR positive | 0 | 2 | 2 | 0.557217 |
Preterm birth | 2 | 7 | 9 | 0.495630 |
Sex of the fetus (boy) | 13 | 52 | 65 | 0.076257 |
Twin pregnancy | 1 | 2 | 3 | 0.348785 |
IVF (ET or ICSI) | 0 | 4 | 4 | 0.402803 |
Infection in the first trimester of pregnancy | 4 | 13 | 17 | 0.257281 |
Fetal Malformation on Ultrasound (218 Livebirths) | |||||||
---|---|---|---|---|---|---|---|
Negative | Positive | Total | Fisher’s Exact Test | ||||
Case | % | Case | % | ||||
Neonatal neurological complications | |||||||
Subcutan oedema | |||||||
Negative | case | 210 | 100.00% | 0 | 0.00% | 210 | |
% | 96.77% | 0.00% | |||||
Positive | case | 7 | 87.50% | 1 | 12.50% | 8 | |
% | 3.23% | 100% | |||||
Total | 217 | 99.54% | 1 | 0.46% | 218 | 0.037 | |
Craniospinal malformations | |||||||
Negative | case | 181 | 86.19% | 29 | 13.81% | 210 | |
% | 96.28% | 96.67% | |||||
Positive | case | 7 | 87.50% | 1 | 12.50% | 8 | |
% | 3.72% | 3.33% | |||||
Total | 188 | 86.24% | 30 | 13.76% | 218 | 0.697 | |
Cardiovascular malformations | |||||||
Negative | case | 192 | 91.43% | 18 | 8.57% | 210 | |
% | 96.00% | 100% | |||||
Positive | case | 8 | 100.00% | 0 | 0.00% | 8 | |
% | 4.00% | 0% | |||||
Total | 200 | 91.74% | 18 | 8.26% | 218 | 0.697 | |
Pulmonary malformations | |||||||
Negative | case | 209 | 99.52% | 1 | 0.48% | 210 | |
% | 96.31% | 0.00% | |||||
Positive | case | 8 | 100.00% | 0 | 0.00% | 8 | |
% | 3.23% | 0.00% | |||||
Total | 217 | 99.54% | 1 | 0.46% | 218 | 0.963 | |
Urogenital malformations | |||||||
Negative | case | 203 | 96.67% | 7 | 3.33% | 210 | |
% | 96.21% | 100.00% | |||||
Positive | case | 8 | 100.00% | 0 | 0.00% | 8 | |
% | 3.79% | 0.00% | |||||
Total | 211 | 96.79% | 7 | 3.21% | 218 | 0.767 | |
Hepatic malformations | |||||||
Negative | case | 203 | 96.67% | 7 | 3.33% | 210 | |
% | 96.21% | 100.00% | |||||
Positive | case | 8 | 100.00% | 0 | 0.00% | 8 | |
% | 3.79% | 0.00% | |||||
Total | 211 | 96.79% | 7 | 3.21% | 218 | 0.767 | |
Gastrointestinal malformations | |||||||
Negative | case | 170 | 80.95% | 40 | 19.05% | 210 | |
% | 95.51% | 100.00% | |||||
Positive | case | 8 | 100.00% | 0 | 0.00% | 8 | |
% | 4.49% | 0.00% | |||||
Total | 178 | 81.65% | 40 | 18.35% | 218 | 0.192 |
Fetal Malformation on Ultrasound (218 Livebirths) | |||||||
---|---|---|---|---|---|---|---|
Negative | Positive | Total | Fisher’s Exact Test | ||||
Case | % | Case | % | ||||
Neonatal ophthalmological complication | |||||||
Subcutan oedema | |||||||
Negative | case | 209 | 99.05% | 2 | 0.95% | 211 | |
% | 96.76% | 100.00% | |||||
Positive | case | 7 | 100.00% | 0 | 0.00% | 7 | |
% | 3.24% | 0.00% | |||||
Total | 216 | 99.08% | 2 | 0.92% | 218 | 0.937 | |
Craniospinal malformations | |||||||
Negative | case | 181 | 85.78% | 30 | 14.22% | 211 | |
% | 96.28% | 100.00% | |||||
Positive | case | 7 | 100.00% | 0 | 0.00% | 7 | |
% | 3.72% | 0.00% | |||||
Total | 188 | 86.24% | 30 | 13.76% | 218 | 0.349 | |
Cardiovascular malformations | |||||||
Negative | case | 193 | 91.47% | 18 | 8.53% | 211 | |
% | 96.50% | 100.00% | |||||
Positive | case | 7 | 100.00% | 0 | 0.00% | 7 | |
% | 3.50% | 0.00% | |||||
Total | 200 | 91.74% | 18 | 8.26% | 218 | 0.542 | |
Pulmonary malformations | |||||||
Negative | case | 210 | 99.53% | 1 | 0.47% | 211 | |
% | 96.77% | 100.00% | |||||
Positive | case | 7 | 100.00% | 0 | 0.00% | 7 | |
% | 3.23% | 0.00% | |||||
Total | 217 | 99.54% | 1 | 0.46% | 218 | 0.968 | |
Urogenital malformations | |||||||
Negative | case | 204 | 96.68% | 7 | 3.32% | 211 | |
% | 96.68% | 100.00% | |||||
Positive | case | 7 | 100.00% | 0 | 0.00% | 7 | |
% | 3.32% | 0.00% | |||||
Total | 211 | 96.79% | 7 | 3.21% | 218 | 0.793 | |
Hepatic malformations | |||||||
Negative | case | 205 | 97.16% | 6 | 2.84% | 211 | |
% | 97.16% | 85.71% | |||||
Positive | case | 6 | 85.71% | 1 | 14.29% | 7 | |
% | 2.84% | 14.29% | |||||
Total | 211 | 96.79% | 7 | 3.21% | 218 | 0.207 | |
Gastrointestinal malformations | |||||||
Negative | case | 172 | 81.52% | 39 | 18.48% | 211 | |
% | 96.63% | 97.50% | |||||
Positive | case | 6 | 85.71% | 1 | 14.29% | 7 | |
% | 3.37% | 2.50% | |||||
Total | 178 | 81.65% | 40 | 18.35% | 218 | 0.622 |
Codaccioni et al. [26] | Hohlfeld et al. [27] | Results of the Present Study | |
---|---|---|---|
Number of cases | 88 | 89 | 133 |
Intracranial abnormalities | |||
Ventriculomegaly | 44 (50%) | 25 (28%) | 13 (9.8%) |
Abnormalities affecting ventricle IV | not tested | not tested | 2 (1.5%) |
Choroid plexus cyst | not tested | not tested | 21 (15.8%) |
Nervous system calcification | 5 (5.7%) | 6 (6.7%) | 5 (3.8%) |
Abnormalities affecting the gastrointestinal system | |||
Echodense liver | not tested | 4 (4.5%) | 8 (6%) |
Echodense intestines | 11 (12.5%) | not tested | 42 (36.6%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tűzkő, N.; Bartek, V.; Simonyi, A.; Harmath, Á.; Szabó, I.; Virok, D.P.; Beke, A. Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis. Children 2024, 11, 1111. https://doi.org/10.3390/children11091111
Tűzkő N, Bartek V, Simonyi A, Harmath Á, Szabó I, Virok DP, Beke A. Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis. Children. 2024; 11(9):1111. https://doi.org/10.3390/children11091111
Chicago/Turabian StyleTűzkő, Nándor, Virág Bartek, Atene Simonyi, Ágnes Harmath, István Szabó, Dezso Peter Virok, and Artur Beke. 2024. "Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis" Children 11, no. 9: 1111. https://doi.org/10.3390/children11091111
APA StyleTűzkő, N., Bartek, V., Simonyi, A., Harmath, Á., Szabó, I., Virok, D. P., & Beke, A. (2024). Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis. Children, 11(9), 1111. https://doi.org/10.3390/children11091111